Abstract
The prognosis of patients with unresectable intracerebral primary and metastatic tumours that recur following cranial irradiation is poor. Chemotherapy agents have been of limited value. PCNU — a new nitrosourea, has been shown to have the optimum log P for treatment of murine intracerebral tumours. We conducted a preclinical toxicological study of intracarotid injection of PCNU in dogs. Our results show that there was no major neurological or retinal toxicity from the drug, suggesting that PCNU may be less toxic than the presently available BCNU.
Similar content being viewed by others
References
Chen HG, Gross JF: Intra-arterial infusion of anticancer drugs: Theoretic Aspects of Drug Delivery and Review of Responses. Cancer Treat Rep 64:31–40, 1980
Fenstermacher JD, Cowles AL: Theoretic limitations of intracarotid infusions in brain tumour chemotherapy. Cancer Treat Rep 61:519–526, 1977
Stewart DJ, Benjamin RS, Luna M, Feun L, Caprioli R, Seifert WE, Loo TL: Human tissue distribution of platinum after Cis-diamminedichloroplatinum. Cancer Chemother Pharmacol 10:51–54, 1982
Stewart DJ: Novel modes of chemotherapy administration. In: Rosenblum ML and Wilson LB (eds) Prog Exp Tumor Res vol 28:32–50 (Karger, Basel 1984)
Vick NA, Khandekar JD, Bigner DD: Chemotherapy of brain tumors. The “blood-brain barrier is not a factor”. Arch Neurol 34:523–526, 1977
Stewart DJ, Leavens M, Maor M, Feun L, Luna M, Bonura J, Caprioli R, Loo TL, Benjamin RS: Human central nervous system distribution of Cis-diamminedichlorplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 42:2474–2479, 1982
Levin VA, Wilson CB: Pharmacologic considerations in brain tumor chemotherapy. In: Fewer D, Wilson C, Levin V (eds) Brain tumor chemotherapy. Springfield and Thomas, 1976, pp 56–60
Groothuis DR, Fischer JM, Vick NA, Bigner DD: Comparative permeability of different glioma models to horse-radish peroxidase. Cancer Treat Rep 65 (Suppl 2):13–18, 1981
Crafts DC, Wilson CB: Basis and results of chemotherapeutic treatment of gliomas. Bulletin du Cancer 64:101–114, 1977
Madajewicz S, West CR, Park HY, Ghoorah J, Avellanosa AM, Takita H, Karakousis C, Vincent R, Caracandas J, Jennings E: Phase II study — intra-arterial BCNU therapy for metastatic brain tumours. Cancer 47:653–657, 1981
Greenberg HS, Ensminger WD, Seeger JF, Kindt GW Chandler WF, Doan K, Dakhil SR: Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system: A preliminary report. Cancer Treat Rep 65:803–810, 1981
Levin VA, Kabra P: Effectiveness of the nitrosoureas as a function of their lipid solubility in the chemotherapy of experimental rat brain tumors. Cancer Chemother Rep 58:787–792, 1974
A summary of the activity of PCNU, NSC 95466. National Cancer Institute Report. June 29, 1978
Report NSC 95466 urea 1-(2-chloroethyl)-3-(26-dioxo-l-piperidyl)-l-nitrosourea. National Cancer Institute Report M RIKC-PT 3809-77-12, March, 1978
DeWys WD, Fowler EH: Report of vasculitis and blindness after intra-carotid injection of 1–3-bis(2-chloroethyl)-1-nitrosourea (BCNU, NSC 40 9962) in dogs. Cancer Chemother Rep 57:33–40, 1973
Crafts DC, Levin VA, Nielsen S: Intracarotid BCNU (NSC 409962): A toxicity study in six rhesus monkeys. Cancer Treat Rep 60:541–545, 1976
Stewart DJ, Benjamin RS, Leavens M, Valdivieso M, Burgess MA,Bodey GP: Phase I studyof 1-(2-chloroethyl)-3–12,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466) in adults with solid tumors. Cancer Research 40:3750–3754, 1980
Fenn LG, Stewart DJ, Leavens ME, Burgess MA, Savaraj N, Benjamin RS, Bodey GP: A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-l-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors. J Neuro-Oncology 1:45–48, 1983
Miller ME, Christensen GC, Evans HE: Anatomy of the dog. Philadelphia, WB Saunders Co, 1964, pp 289–324
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goumnerova, L., Richard, M.T., Addison, D. et al. Intracarotid infusion of PCNU (NSC: 95466): Preclinical toxicological study in dogs. J Neuro-Oncol 5, 205–209 (1987). https://doi.org/10.1007/BF00151223
Issue Date:
DOI: https://doi.org/10.1007/BF00151223